Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker, Róbert Královics
Blood (2016) Vol. 129, Iss. 6, pp. 667-679
Open Access | Times Cited: 531

Showing 1-25 of 531 citing articles:

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, et al.
Blood Cancer Journal (2018) Vol. 8, Iss. 2
Open Access | Times Cited: 543
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, et al.
The Lancet Haematology (2020) Vol. 7, Iss. 3, pp. e196-e208
Open Access | Times Cited: 268
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms
Elisa Rumi, Mario Cazzola
Blood (2016) Vol. 129, Iss. 6, pp. 680-692
Open Access | Times Cited: 226
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
Bettina Wingelhofer, Heidi A. Neubauer, Peter Valent, et al.
Leukemia (2018) Vol. 32, Iss. 8, pp. 1713-1726
Open Access | Times Cited: 209
Life histories of myeloproliferative neoplasms inferred from phylogenies
Nicholas Williams, Joe Lee, Emily Mitchell, et al.
Nature (2022) Vol. 602, Iss. 7895, pp. 162-168
Open Access | Times Cited: 205
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis
Moshe Talpaz, Jean‐Jacques Kiladjian
Leukemia (2020) Vol. 35, Iss. 1, pp. 1-17
Open Access | Times Cited: 146
Genetic basis and molecular profiling in myeloproliferative neoplasms
Damien Luque Paz, Róbert Královics, Radek C. Skoda
Blood (2022) Vol. 141, Iss. 16, pp. 1909-1921
Open Access | Times Cited: 82
Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management
Ayalew Tefferi, Tiziano Barbui
American Journal of Hematology (2023) Vol. 98, Iss. 9, pp. 1465-1487
Open Access | Times Cited: 79
Myelofibrosis
Francesco Passamonti, Barbara Mora
Blood (2022) Vol. 141, Iss. 16, pp. 1954-1970
Open Access | Times Cited: 70
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management
Ayalew Tefferi, Alessandro M. Vannucchi, Tiziano Barbui
American Journal of Hematology (2024) Vol. 99, Iss. 4, pp. 697-718
Open Access | Times Cited: 42
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis
Aaron T. Gerds, Claire Harrison, Jean‐Jacques Kiladjian, et al.
Blood Advances (2024) Vol. 8, Iss. 17, pp. 4511-4522
Open Access | Times Cited: 17
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders
William Vainchenker, Emilie Leroy, Laure Gilles, et al.
F1000Research (2018) Vol. 7, pp. 82-82
Open Access | Times Cited: 142
Genetic predisposition to MDS: clinical features and clonal evolution
Alyssa L. Kennedy, Akiko Shimamura
Blood (2019) Vol. 133, Iss. 10, pp. 1071-1085
Open Access | Times Cited: 125
Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling
Daniel A.C. Fisher, Cathrine A. Miner, Elizabeth K. Engle, et al.
Leukemia (2019) Vol. 33, Iss. 8, pp. 1978-1995
Open Access | Times Cited: 124
Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond
Emery H. Bresnick, Kyle J. Hewitt, Charu Mehta, et al.
Development (2018) Vol. 145, Iss. 1
Open Access | Times Cited: 123
Inflammation and myeloproliferative neoplasms
Federico Lussana, Alessandro Rambaldi
Journal of Autoimmunity (2017) Vol. 85, pp. 58-63
Closed Access | Times Cited: 121
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
Ulrike Bacher, Evgenii Shumilov, Johanna Flach, et al.
Blood Cancer Journal (2018) Vol. 8, Iss. 11
Open Access | Times Cited: 112
JAK2 inhibitors for myeloproliferative neoplasms: what is next?
Prithviraj Bose, Srđan Verstovšek
Blood (2017) Vol. 130, Iss. 2, pp. 115-125
Open Access | Times Cited: 99
Polycythemia vera: historical oversights, diagnostic details, and therapeutic views
Ayalew Tefferi, Alessandro M. Vannucchi, Tiziano Barbui
Leukemia (2021) Vol. 35, Iss. 12, pp. 3339-3351
Open Access | Times Cited: 97
Megakaryocyte and polyploidization
Stefania Mazzi, Larissa Lordier, Najet Debili, et al.
Experimental Hematology (2017) Vol. 57, pp. 1-13
Open Access | Times Cited: 96
Immunosuppression by Mutated Calreticulin Released from Malignant Cells
Peng Liu, Liwei Zhao, Friedemann Loos, et al.
Molecular Cell (2019) Vol. 77, Iss. 4, pp. 748-760.e9
Open Access | Times Cited: 96
Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
Shayda Hemmati, Tamanna Haque, Kira Gritsman
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 90
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Daniel Arthur Corpuz Fisher, Jared S. Fowles, Amy Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 82
CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice
Amy E. DeZern, Luca Malcovati, Benjamin L. Ebert
American Society of Clinical Oncology Educational Book (2019), Iss. 39, pp. 400-410
Closed Access | Times Cited: 79
Germline risk of clonal haematopoiesis
Alexander J. Silver, Alexander G. Bick, Michael R. Savona
Nature Reviews Genetics (2021) Vol. 22, Iss. 9, pp. 603-617
Open Access | Times Cited: 67
Page 1 - Next Page

Scroll to top